None
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1) Subject, aged from 20 to 39 years (bounds included) 2) Subject having sports with lower limbs more than 2 days a week 3) Subject classified as more than good grade of the PWC75%HRmax score on the physical work capacity on a cycle ergometer 4)Subject who can have a cycle ergometer exercise with more than 60 rpm for 12 minutes at the torque in case of 60 rpm of PWC75%HRmax 5) Subject having a briefing of the content of the present study, fully understanding and agreeing to its objective and being able to personally sign a written informed consent
Exclusion criteria
Exclusion criteria: 1) Subject taking any medical treatment(prescribed a medicine by a doctor) 2) Subject receiving a medical treatment for serious renal, hepatic, cardio-vascular, respiratory, endocrine or metabolic disorders or having a medical history of these disorders 3) Subject having a medical history of a chest pain or swoon career 4) Subject having a subjective symptom of low back pain, arthralgia or lumber hernia, disease of lower limbs, palpitations 5) Subject having an abnormality in the electrocardiogram 6) Subject having the possibilty of developing allergic symptoms by test food 7) Subject having blood sample of 200 ml or more taken (e.g., donated blood) within 1 month, or 400 ml or more within 3 months prior to the start of the present study 8) Subject having the habit of taking a supplement 9) Subject received a serious injury within past 1 year 10) Subject taking part in any sports events during the present study period or within 1 month before and after the period 11) Subject going abroad or having a trip for more than 3 days and 2 nights during the present study 12) Subject having a smoking habit 13) Subject having a seasonal allergy of a cedar or Japanese cypress pollen 14) Subject who took part in another clinical trial within 3 months prior to the start of the present study or who is currently taking part in another clinical trial 15) Subject judged to be ineligible by the investigator for other reason
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 4km cycling time trial performance | — |
Secondary
| Measure | Time frame |
|---|---|
| bloodchemisty(NOx), VO2 and visual analogue scale | — |
Countries
Japan
Contacts
Soiken Inc. R&D Division